Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vebicorvir Phase 1b/2a in Chronic Hepatitis B
NCT03109730Phase 2Completed
- Sponsor
- Assembly Biosciences, Inc.
- Start
- Jun 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of vebicorvir in Chronic Hepatitis B (CHB), sponsored by Assembly Biosciences, Inc.. Started Jun 2017; status: completed.
02
Drugs
vebicorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03109730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03109730.